Kallikrein 15 antibody (Middle Region)
Quick Overview for Kallikrein 15 antibody (Middle Region) (ABIN953102)
Target
See all Kallikrein 15 (KLK15) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 79-106, Middle Region
-
Specificity
- This antibody recognizes Human KLK15 / Kallikrein-15 (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 79-106 amino acids from the Central region of Human KLK15 / Kallikrein-15
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Kallikrein 15 (KLK15) (Kallikrein-Related Peptidase 15 (KLK15))
-
Alternative Name
- KLK15 / Kallikrein-15
-
Background
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. In prostate cancer, this gene has increased expression, which indicates its possible use as a diagnostic or prognostic marker for prostate cancer. The gene contains multiple polyadenylation sites and alternative splicing results in multiple transcript variants encoding distinct isoforms.Synonyms: ACO protease
-
Molecular Weight
- 18kd
-
Gene ID
- 55554
-
NCBI Accession
- NP_059979
-
Pathways
- Complement System
Target
-